About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Stigma Associated With Alzheimer’s Disease, a Major Obstacle in Prevention Research

by Anjali Aryamvally on March 28, 2018 at 10:03 AM
Font : A-A+

Stigma Associated With Alzheimer’s Disease, a Major Obstacle in Prevention Research

A national survey found that the stigma associated with Alzheimer's disease may be an obstacle for people to seek information about their risk of developing the disease and to participate in clinical studies that discover potential therapies. The survey was based on what beliefs, attitudes and expectations are most often associated with Alzheimer's disease. The survey results are published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

"We found that concerns about discrimination and overly harsh judgments about the severity of symptoms were most prevalent," said Shana Stites, Psy.D., from the Perelman School of Medicine, University of Pennsylvania. "By understanding what the biggest concerns are about the disease, we can help develop programs and policies to reduce the stigma about Alzheimer's disease."

Advertisement


The random sample of 317 adults was asked to react to a fictional description of a person with mild stage Alzheimer's disease dementia. The study asked respondents to read a vignette and then complete the survey. Three different assessments were presented for the fictional person's condition. Respondents were told the person's condition would worsen, improve or remain unchanged.

Over half of the respondents (55 percent) expected the person with mild cognitive impairment or dementia due to Alzheimer's to be discriminated against by employers and to be excluded from medical decision-making. Almost half expected the person's health insurance would be limited due to data in the medical record (47 percent), a brain imaging result (46 percent) or genetic test result (45 percent). Those numbers increased when the survey participants were informed that the condition of the person with Alzheimer's would worsen over time.
Advertisement

The study findings suggest respondents continue to have concerns about documentation in the medical record or test results, despite the fact that there are some protections in place against gene-based health care insurance discrimination through the Genetic Information Nondiscrimination Act of 2008 (GINA). However, those concerns of the public also include issues not addressed by that legislation, including brain imaging results.

In addition, the study authors found that when told the fictional person's prognosis would improve over time, 24 percent to 41 percent fewer respondents expected that the person would encounter discrimination or exclusion than when told the person's prognosis would worsen. According to the researchers, this suggests that advances in therapies that improve the prognosis of Alzheimer's could help reduce stigma.

"The unfortunate stigma associated with Alzheimer's may prevent people from getting the diagnosis they need or the opportunity for early intervention that could improve their quality of life," said Maria C. Carrillo, Ph.D., Chief Science Officer, Alzheimer's Association. "We need to reduce the stigma to encourage persons with mild or even no symptoms of Alzheimer's disease to enroll in prevention trials to find effective treatments. These survey findings could also have implications on the national goal of developing an effective therapy by 2025." Dr. Carrillo stressed the importance of early diagnosis for people with Alzheimer's disease and related dementias and their families to provide more time to plan for the future by participating in decisions about treatments, living options, financial and legal matters, as well as building a care team to making it easier to manage the disease. In the article's conclusion, the authors state that public education and policies are needed to shift Alzheimer's disease stigma by addressing these concerns about potential discrimination based on genetic and biomarker test results that may be keeping people from learning their own results and participating in prevention clinical trials.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
Long-Term Glycemic Control - A Better Measure of COVID-19 Severity
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Amyotrophic Lateral Sclerosis (ALS) Acute Coronary Syndrome 

Recommended Reading
Genetics of Alzheimer´s disease
There are numerous genes that have been discovered that are associated with Alzheimer's disease and ...
Can Painkillers Help Prevent Alzheimer’s Disease?
A daily regimen of the non-prescription NSAID ibuprofen can prevent the onset of Alzheimer's ......
Strong Influence of the Cardiovascular System on Alzheimer’s Disease
For the first time, study presents a close relationship between Alzheimer's disease and problems ......
Improving Brain Function in Alzheimer’s Disease is Possible by Cell Therapy
A special type of neuron called inhibitory interneuron, when transplanted into brain can restore ......
Acute Coronary Syndrome
Acute coronary syndrome (ACS) is a sudden, acute life-threatening condition caused by a dramatic red...
Amyotrophic Lateral Sclerosis (ALS)
Find out more about the degenerative disease- Amyotrophic lateral sclerosis....

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use